drugset / Trial / NCT04252586
A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NaSingle-groupOpen-labelTreatment
Summary
This study will be conducted to evaluate the long-term safety of cannabidiol oral solution (GWP42003-P, CBD-OS) in participants with Rett syndrome.
Timeline
- Start
- 2020-02-28
- Primary completion
- 2021-06-09
- Completion
- 2021-06-09
Outcome
Outcome not reported
Stopped (Enrollment): “Study was terminated due to COVID-19 pandemic and recruitment challenges in the parent study (GWND18064 - NCT03848832).”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 100 mg/ml | Oral |